Sign inJoin free

Watch / Company News

Market Update | Pro Medicus, Insurance Australia Group, Credit Corp, Dyno Nobel, Worley, Caterpillar, RPM Global, Genesis Minerals, Virgin Australia, Austal, Bapcor, Harvey Norman, Activeport, Megaport, Recce Pharmaceuticals, 4D Medical

1 Sept 20250:56

Market Update | Pro Medicus, Insurance Australia Group, Credit Corp, Dyno Nobel, Worley, Caterpillar, RPM Global, Genesis Minerals, Virgin Australia, Austal, Bapcor, Harvey Norman, Activeport, Megaport, Recce Pharmaceuticals, 4D Medical

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Pro Medicus (ASX: PME) has risen after its US subsidiary, Visage Imaging, received an Authority to Operate for its Visage 7 platform from the US Department of Veterans' Affairs within the Veterans Affairs Enterprise Cloud.

Insurance Australia Group (ASX: IAG) shares climbed after an $855 million deal secured a 90% stake in RACQ’s underwriting business along with a 25-year distribution agreement.

Credit Corp (ASX: CCP) shares fell after the company announced that Ewen Crouch had postponed his start date as a non-executive director. He was originally scheduled to join the board on September 1.

The former CEO of Incitec Pivot, now Dyno Nobel (ASX: DNL), will join the board of Worley (ASX: WOR) as an independent non-executive director. Jeanne Johns will be a member of the Nominations and Audit & Risks committees.

The American company Caterpillar (ASX: CAT) has made a bid for RPM Global (ASX: RUL) at $5 a share. This is a non-binding indicative proposal, but the mining equipment and mining software companies have entered into an exclusivity arrangement. The board of RPM Global intends to recommend that shareholders support the deal.

Genesis Minerals (ASX: GMD) has more than doubled its exploration budget for FY26 to between $40 and $50 million. Genesis Minerals says it is especially confident in its Leonora and Laverton assets.

Morningstar has raised its fair value estimate for Virgin Australia (ASX: VGN) to $2.80 following the airline's upgrade of its near-term earnings guidance. The broker expects higher fares and fuller planes for Virgin in FY26 but notes this could attract competition in the medium term.

Citi has raised its target price on Austal (ASX: ASB) by 12% to $7.86 after the shipbuilder's profit beat estimates. Citi says Austal is well-placed to benefit from rising defense spending in the US and Australia and adds that new construction contracts are likely to be announced soon. Founder and non-executive director John Rothwell announced he will step down after 38 years with Austal.

Citi has lowered its earnings forecast for Bapcor (ASX: BAP), citing higher costs. The broker maintains its neutral rating on the stock with a $3.90 target price.

Analysts at Jefferies have raised their price target on Harvey Norman (ASX: HVN) to A$7.80 from A$6.50 after its FY profit and sales beat expectations. The broker says FY26 has "started well" for the furniture and electronics retailer, with sales growing faster than peers.

Activeport (ASX: ATV) is partnering with Megaport (ASX: MP1) to increase interconnection among telco operators in Asia. Activeport aims to create a network-to-network service to enable telco providers to operate more efficiently across Asian countries. The partnership with Megaport is intended to create a virtual data centre network.

Preliminary results from Recce Pharmaceuticals (ASX: RCE) show the company widened its loss in FY25, increasing from $16.66 million in FY24 to $21.43 million in FY25. Recce Pharma attributes this to increased spending on R&D and will not declare a dividend for the past financial year.

4D Medical (ASX: 4DX) has received US FDA approval for its lung imaging technology CT:VQ. The company says the addressable market is worth around US$1.1 billion.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy